Aquestive Therapeutics In... (AQST)
3.21
0.09 (2.88%)
At close: Mar 27, 2025, 3:59 PM
3.15
-2.01%
After-hours: Mar 27, 2025, 07:55 PM EDT
Aquestive Therapeutics Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Revenue | 57.56M | 50.58M | 47.68M | 50.83M | 45.85M | 52.61M | 67.43M | 66.92M | 51.78M |
| Cost of Revenue | 17.87M | 20.83M | 19.39M | 14.99M | 12.96M | 20.36M | 20.99M | 19.82M | 16.38M |
| Gross Profit | 39.69M | 29.75M | 28.29M | 35.84M | 32.88M | 32.25M | 46.44M | 47.1M | 35.41M |
| Operating Income | -30.77M | -15.1M | -42.07M | -34.68M | -42.89M | -52.67M | -48.93M | -113K | -847K |
| Interest Income | 3.44M | 16.32M | 99K | 423K | 132K | 636K | 552K | n/a | n/a |
| Pretax Income | -44.15M | -7.63M | -54.41M | -70.54M | -55.78M | -66.25M | -61.38M | -8.94M | -9.6M |
| Net Income | -44.14M | -7.87M | -60.2M | -90.04M | -65.36M | -72.66M | -61.38M | -8.94M | -9.6M |
| Selling & General & Admin | 50.18M | 31.75M | 52.88M | 53.48M | 55.89M | 64.34M | 72.26M | 25.08M | 20.8M |
| Research & Development | 20.28M | 13.1M | 17.48M | 17.05M | 19.89M | 20.57M | 23.11M | 22.13M | 15.45M |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -5K | n/a | -99K |
| Operating Expenses | 70.46M | 44.85M | 70.36M | 70.52M | 75.78M | 84.92M | 95.38M | 47.21M | 36.25M |
| Interest Expense | 16.82M | 7.46M | 12.44M | 22.46M | 13.02M | 9.32M | 7.71M | 7.71M | 6.14M |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 88.33M | 65.69M | 89.75M | 85.51M | 88.74M | 105.28M | 116.36M | 67.03M | 52.63M |
| Income Tax | -14K | 245K | 5.79M | 19.5M | 9.58M | 6.41M | -4.73M | 7.71M | 6.04M |
| Shares Outstanding (Basic) | 86.73M | 61.26M | 48.73M | 38.08M | 33.65M | 25.36M | 20.73M | 20M | 24.5M |
| Shares Outstanding (Diluted) | 86.73M | 61.26M | 48.73M | 38.08M | 33.65M | 25.36M | 20.73M | 20M | 24.5M |
| EPS (Basic) | -0.51 | -0.13 | -1.24 | -2.36 | -1.94 | -2.87 | -2.96 | -0.45 | -0.39 |
| EPS (Diluted) | -0.51 | -0.13 | -1.24 | -2.36 | -1.94 | -2.87 | -2.96 | -0.45 | -0.39 |
| EBITDA | -26.62M | 1.18M | -39.58M | -45.11M | -39.15M | -53.88M | -50.33M | 2.56M | 2.94M |
| Depreciation & Amortization | 718K | 1.34M | 2.39M | 2.96M | 3.61M | 3.05M | 3.34M | 3.8M | 3.89M |